PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...
Got a new iPad for the holidays? Follow these essential setup and security steps to protect your data and start strong from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback